Health Sciences

Penn Medicine Physician Finds No Preventive Benefits for Widely Used Kidney Cancer Drugs

Two widely used targeted therapy drugs— approved by the FDA for use in metastatic kidney cancer —are no more effective than a placebo in preventing return of the disease to increase life spans of patients suffering from advanced kidney cancer after surgery, according to new results to be presented by a researcher at the University of Pennsylvania’s 

Steve Graff

Penn Medicine Study Describes Development of Personalized Cellular Therapy for Brain Cancer

Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Science Translational Medicine by a team from the Perelman School of Medicine at the University of Pennsy

Holly Auer

Sharp, Sustained Increases in Suicides Closely Shadowed Austerity Events in Greece, Penn Study Finds

Sharp and significant increases in suicides followed select financial crisis events and austerity announcements in Greece, from the start of the country’s 2008 recession to steep spending cuts in 2012, Penn Medicine researchers report in a new study published online this week in the British  Medical Journal Open, along with colleagues from Greece and the United Kingdom.

Steve Graff



In the News


Slate.com

What’s going on with tranq?

Jeanmarie Perron of the Perelman School of Medicine says that the appearance and progression of skin ulcers and tissue loss on xylazine users is different than with other intravenous drugs.

FULL STORY →



The Hill

It’s time to end the Medicare-Medicaid merry-go-round

In an opinion essay, Rachel M. Werner of the Leonard Davis Institute, Wharton School, and Perelman School of Medicine says that Medicare and Medicaid fail to integrate coverage and coordinate care across their two plans.

FULL STORY →



The Wall Street Journal

The quest for treatments to keep weight off after Ozempic

Researchers at Penn are conducting a co-authored study of the brains, fat and muscle cells, and eating patterns of people trying to maintain new body sizes.

FULL STORY →



Philadelphia Inquirer

Inside Penn’s transfer center

Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.

FULL STORY →



Philadelphia Inquirer

Operating rooms are major sources of greenhouse gasses. Penn is eliminating a form of anesthesia that hangs in the air for more than a decade after use

Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.

FULL STORY →